Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical characterization and genomic landscape of gynecological cancers among patients attending a Chinese hospital. | Front Oncol | 2023 | 37064128 | PubTator, text mining | PubMed |
| Advances in the multi-omics landscape of follicular lymphoma. | Int J Biol Sci | 2023 | 37063433 | PubTator, text mining | PubMed |
| Branch-duct Intraductal Papillary Mucinous Neoplasm with Rapidly Developing Intracystic Xanthogranulomatous Nodules. | Intern Med | 2023 | 37062735 | PubTator, text mining | PubMed |
| Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. | Blood Cancer J | 2023 | 37055414 | PubTator, text mining | PubMed |
| The engagement of histone lysine methyltransferases with nucleosomes: structural basis, regulatory mechanisms, and therapeutic implications. | Protein Cell | 2023 | 37051671 | PubTator, text mining | PubMed |
| Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways. | Cancers (Basel) | 2023 | 37046795 | PubTator, text mining | PubMed |
| N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer. | Cell Rep Med | 2023 | 37044095 | PubTator, text mining | PubMed |
| Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinoma. | Transl Androl Urol | 2023 | 37032757 | PubTator, text mining | PubMed |
| Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis. | Prog Retin Eye Res | 2023 | 37028118 | PubTator, text mining | PubMed |
| Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma. | Sci Rep | 2023 | 37024613 | PubTator, text mining | PubMed |
| Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37021976 | PubTator, text mining | PubMed |
| Research progress on exosomes in podocyte injury associated with diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37020588 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| LncRNA LINC00205 stimulates osteoporosis and contributes to spinal fracture through the regulation of the miR-26b-5p/KMT2C axis. | BMC Musculoskelet Disord | 2023 | 37016415 | PubTator, text mining | PubMed |
| Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. | Cell Mol Biol Lett | 2023 | 37016296 | PubTator, text mining | PubMed |
| Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification. | Acta Neuropathol | 2023 | 37014508 | PubTator, text mining | PubMed |
| Extracellular vesicles in tumor angiogenesis and resistance to anti-angiogenic therapy. | Cancer Sci | 2023 | 37010195 | PubTator, text mining | PubMed |
| A Computational Approach to Predict the Role of Genetic Alterations in Methyltransferase Histones Genes With Implications in Liver Cancer. | Cancer Inform | 2023 | 37008071 | PubTator, text mining | PubMed |
| Targeted sequencing and clinical strategies in children with autism spectrum disorder: A cohort study. | Front Genet | 2023 | 37007974 | PubTator, text mining | PubMed |
| Noninvasive genomic profiling of somatic mutations in oral cavity cancers. | Oral Oncol | 2023 | 37004423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=35